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Background: Increasingly evidence is emerging from south East Asia, southern and east Africa on the burden of
default to follow up care after a positive cervical cancer screening/diagnosis, which impacts negatively on cervical
cancer prevention and control. Unfortunately little or no information exists on the subject in the West Africa sub
region. This study was designed to determine the proportion of and predictors and reasons for default from follow
up care after positive cervical cancer screen.
Method: Women who screen positive at community cervical cancer screening using direct visual inspection were
followed up to determine the proportion of default and associated factors. Multivariate logistic regression was used
to determine independent predictors of default.
Results: One hundred and eight (16.1%) women who screened positive to direct visual inspection out of 673 were
enrolled into the study. Fifty one (47.2%) out of the 108 women that screened positive defaulted from follow-up
appointment. Women who were poorly educated (OR: 3.1, CI: 2.0 – 5.2), or lived more than 10 km from the clinic
(OR: 2.0, CI: 1.0 – 4.1), or never screened for cervical cancer before (OR: 3.5, CI:3:1–8.4) were more likely to default
from follow-up after screening positive for precancerous lesion of cervix . The main reasons for default were cost of
transportation (48.6%) and time constraints (25.7%).
Conclusion: The rate of default was high (47.2%) as a result of unaffordable transportation cost and limited time to
keep the scheduled appointment. A change from the present strategy that involves multiple visits to a “see and treat”
strategy in which both testing and treatment are performed at a single visit is recommended.
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Every year half a million women are diagnosed with cer-
vical cancer and another 250,000 reported dead from the
disease, which makes cancer of the cervix the second most
common female cancer globally [1-3]. It is thus a major
public health challenge especially in resource-poor set-
tings of sub Saharan Africa and south east Asia where it
accounts for most of the morbidity and mortality attribut-
able to cancer in women [4,5]. In these settings, over 80%* Correspondence: oezechi@yahoo.co.uk
1Clinical Sciences Division, Nigerian Institute of Medical Research, Lagos,
Nigeria
2Social Medicine and Global Health, Faculty of Medicine, Lund University,
Lund, Sweden
© 2014 Ezechi et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orof cases of cervical cancer presents in the late stage when
very little can be done [4,5]. Late-stage disease is associ-
ated with low survival rates even after the use of surgery
and/or radiotherapy. In addition, these treatment modal-
ities may be lacking altogether, or be too expensive and in-
accessible for many women in low-resource settings.
Cervical cancer is potentially preventable, and effective
screening programmes can lead to a significant reduc-
tion in the morbidity and mortality it causes [3,6,7]. In
sub-Saharan Africa, there are few organized efforts to
ensure that women over the age of 30 years are screened
[6,8]. Consequently women with cervical cancer are not
identified until they are at an advanced stage of disease,
resulting in high morbidity and mortality [9].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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to women in all populations in high income countries has
been shown to reduce cancer of the cervix rates by
60–90% within three years of implementation [10,11].
While the high-income countries have successfully used
this method to reduce the burden and deaths associated
with cervical cancer, most low income countries have
not succeeded in a similar manner due to inadequate
human and infrastructural resources [3,4]. This chal-
lenge prompted the introduction and adoption of the
low cost technology screening programme based on dir-
ect visual inspection (DVI) of the cervix in sub-Saharan
Africa and south east Asia [10,12-14]. While countries
such as India, Thailand and Zambia [15-17] have imple-
mented this strategy with a positive impact both on the
burden and the mortality, several nations including Nigeria
are yet to implement the strategy successfully [13,18-21].
In Nigeria, cervical cancer screening services using vis-
ual inspection is not yet institutionalised despite its adop-
tion by the Nigerian government as the prevention and
control strategy of choice [12,22,23]. The cervical cancer
screening is largely opportunistic during gynaecological
consultations and uncoordinated outreach programmes
often performed by nurses and medical officers [12,20].
Moreover women found positive at the outreach pro-
grammes are referred for confirmation at a tertiary facility
several kilometres away [20,24]. There is consequently a
risk of drop-out in such a system, as the women have to
make multiple visits for confirmation of screening result
and treatment [23-27].
In low-income countries, returning for follow-up care
after screening positive can be a challenge for women
due to sociocultural, financial, practical, and logistical
barriers. Others may not return for follow-up visits be-
cause they do not properly understand the importance
of further evaluation or are afraid of receiving bad news
about their condition. Others may not return due to
embarrassment or a fear of diagnosis or treatment as re-
ported by researchers in Nigeria, England and Uganda
[22,25-29]. Increasingly evidence is emerging from south
east Asia and sub-Saharan Africa on the burden of non-
adherence to follow-up care after a positive cervical can-
cer screening/diagnosis and its impact on cervical cancer
control in low and medium income countries [25-28].
Default rates in programs designed to identify cervical
cancer at precancerous stages are usually very high, ran-
ging from 5-20% in high income countries and 20-41%
in low income countries [24,29-32].
Although there are studies from our sub-region report-
ing on default in pap smear based screening programmes
[18,20-22], detailed literature search showed few studies
reporting the level of default and the reasons for it after
screening positive to DVI during community outreach
cervical cancer screening [24].In June 2011, the Nigerian Institute of Medical Research
(NIMR) in Lagos, the largest city in Nigeria, initiated a
community based outreach cervical cancer screening
programme as a corporate social responsibility after suc-
cessfully integrating cervical cancer screening into its HIV
care services [23]. However, few months into the outreach
services, a substantial default was noted from the follow-
up appointment for women that had tested positive. The
need to confirm this preliminary finding prompted this
study, which is a part of a larger study on the interaction
between HIV, HPV and cervical premalignant lesions. In-
formation obtained may assist to improve the quality of
the programme and other similar programmes [10,12,18].
The overall aim of this study was to investigate the
magnitude of default and factors associated with default
from follow-up care after screening positive to cervical
precancerous lesion using direct visual inspection.
Methods
Study setting
Four urban and 6 rural communities in the south western
Nigerian states of Lagos and Ogun that participated in
community outreach cervical cancer screening programme
conducted by NIMR between October 2011 and December
2012 served as the setting. While three urban (Surulere,
Ikeja and Gbagada) and 4 rural (Mushin, Iju, Ikorodu and
Egbeda) communities were in Lagos State, the remaining
urban (Sagamu) and 2 rural (Ifo and Ibafo) communities
were in Ogun state. The average distance of the communi-
ties to the NIMR ranged from 2 to 70 kilometres. While
the study participants from the rural communities were
largely poor, poorly educated and of low socioeconomic
status, those from the urban communities were compara-
tively of higher educational and socioeconomic status.
However in the urban communities, pockets of urban
slums exist side by side with areas of affluence. This is
often the pattern in most cities in Nigeria and other west
African countries. It is also important to note that though
the communities are in two states, there is no clear demar-
cation between the states as rapid urbanisation had led to
the merger of border communities in the two states.
The Nigerian Institute of Medical Research in Lagos is
the apex medical research Institution in Nigeria and an
agency of the Federal Ministry of Health charged with
the responsibility to conduct research on diseases of pub-




Adult women of known HIV status aged 18 years and
above who screened positive or inconclusive to direct
visual inspection of cervix during community outreach
cervical cancer screening programme and consented to
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ment for this specific study commenced on the 2nd
October 2011 and follow up completed on the 17th
December 2011.
Before the screening proper the women were educated
as a group on cervical cancer screening and the import-
ance of keeping follow-up appointment if found positive
using study informed consent document approved by
the ethics committee. It addressed the following issues;
 What is cervical cancer and its premalignant phase.
 Various strategies for the prevention of cervical
cancer.
 What is cervical screening and why they need to do
the screening?
 Who should have the test?
 The Nigerian cervical cancer screening Programme
and the step in arriving at a definitive diagnosis?
 How reliable is cervical screening?
 Who will carry out the test and how it will be
conducted?
 Follow up schedules after screening.
The main benefits and difficulties of cervical screening
are explained.
Clinical procedures
After signing the Informed Consent Form, information
on sociodemographic characteristics, sexual and repro-
ductive history were collected using study case record
form. All participants were subjected to a thorough pel-
vic examination, in this sequence comprising collection
of the Pap smear, collection of sample for microbio-
logical examination (when indicated) and Direct Visual
Inspection (DVI) using either Acetic Acid (VIA) or
Lugol’s Iodine (VILI). The examinations were performed
by physicians and midwives received training before per-
forming the study procedures.
The women were placed in modified lithotomy pos-
ition and the cervix is exposed with the help of a Cusco’s
bivalve speculum and examined.
Cervical scraping is obtained by placing the Ayres
spatula at the cervical os and rotated gently by 360°
twice. A Smear was prepared by spreading the specimen
uniformly across a pre-labeled glass slide, which was im-
mediately fixed using a commercial fixator containing
95% ethyl alcohol.
After collecting the cervical smear, the same examiner
performed VIA or VILI depending on a predetermined
group allocation.
VIA procedure and interpretation
After collection of the samples for the Pap test and
microbiological test, acetic acid was applied to the cervixthrough embedded cotton at the edge of a sponge hold-
ing forceps. After 1 min, the cervix was illuminated with
a bright lamp and visually examined (‘naked eye’ exam-
ination). Examiners have been trained on how to classify
their visual impression. For statistical purposes, these im-
pressions were grouped as negative or positive. The find-
ings of VIA were recorded using the following criteria:
VIA negative
When any of the following findings were observed: no
acetowhite lesions; faint, ill-defined, bluish white, shiny,
translucent or doubtful acetowhite lesions; dot-like or
streak-like acetowhitening in the columnar epithelium;
white-line like prominent squamocolumnar junction;
acetowhitening on endocervical polyps or on nabothian
cysts; or acetowhite lesions distant from the squamocol-
umnar junction.
VIA positive
When any of the following findings were observed: well-
defined, demarcated, opaque, acetowhite lesions with or
without raised margins, touching or close to the squamo-
columnar junction well-defined, dense circumorificial
acetowhite lesion involving all the four quadrants of the
cervix; condylomata and leukoplakia occurring close to
the squamocolumnar junction turning intensely white
after the application of acetic acid; or dense, opaque,
acetowhite lesions on clinically visible ulceroproliferative
growth of the cervix.
VILI procedure and interpretation
After collection of the samples for the Pap and micro-
biological test, the cervix was stained with Lugol’s iod-
ine. The cervix was illuminated with a bright lamp and
visually examined. Examiners have been trained on how
to classify their visual impression. For statistical purposes,
these impressions were grouped as negative or positive.
The findings of VILI were recorded using the following
criteria.
VILI negative
Homogeneous staining of the cervix was obtained after
application of Lugol’s iodine.
VILI positive
A well-delimited non-staining area was present.
Follow up
After the screening the women were appointed to visit
cervical cancer screening clinic at NIMR for detailed
counselling on the outcome of their test and further
management either in the same or the following week.
Women who did not honour the invitation after two
weeks were contacted by phone or visited at home to
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ment. The women we were able to reach were given
another suitable date for the follow-up visit. The ones
who failed to keep the second appointment or were not
reached were considered defaulters.
All the women who screened positive to DVI during
the community outreach services constitute the study
population.
Sample size determination
The sample size for this study was based on a reference
VIA positive rate obtained in Sagamu Nigeria during the
WHO demonstration project in six African countries
(WHO) of 5.7% [33]. The study sample size was calculated
according to the following formula: N = Zα2P (1-P)/d2,
where Zα is the Z statistic for a 95% confidence level, N is
the sample size, p is the VIA positive rate, and d is the pre-
cision [34]. Based on this calculation, following up 72 DVI
positive women aged 18 years and above was considered
sufficient to identify defaulters. The sample size was how-
ever increased by 25% in anticipation of non-acceptance
to be followed up after testing positive to DVI. A final
minimum sample size of 90 was obtained.
Data collection
Participants who did not keep their appointments were
contacted on the phone or visited at home and resched-
uled for another appointment at a mutually acceptable
convenient time. Participants who missed the rescheduled
appointment were interviewed to obtain quantitative data
on reason(s) for default using study case record forms.
Definition of variables
 Default from follow-up: Women who screened posi-
tive but failed to keep the rescheduled second appoint-
ment or could not be reached. Women who screened
positive and presented at another health facility for
confirmation and or treatment are not included.
 Age: Age at the last birthday.
 Parity: Number of previous births after 28 weeks of
gestation.
 Educational Status: The educational level completed
by the women.
 Occupation: The main income generating activity/
work engaged in by the women.
 Type of community: The communities were
classified into urban or rural depending on
government classification of the community.
 Marital status: The current marital status of the
women (married, divorced, single or widowed)
 Distance of community to clinic: The approximate
distance in kilometres from the women’s community
to NIMR clinic. Current use of contraceptive: women who were
using a modern method of contraceptive at the
time of study.
 Previous cervical cancer test: Women who had
previously tested for cervical cancer irrespective of
method.
Data analysis
Information on the case record forms were coded and
analyzed using the SPSS version 19.0 (SPSS Inc. Chicago,
IL) statistical packages. The main outcome variable was
default from follow-up care after a positive screen to
DVI. The outcome variable was examined against a set
of independent variables (Sociodemographic, reproduct-
ive and residency characteristics) in order to determine
factors that were associated with default to follow-up
care. Bivariate analysis involved the use of Chi-squared
tests to assess the significance of associations. Multivari-
ate logistic-regression models were used to identify
predictors of default from follow-up care. Because the
number of events was small for prediction, we sought to
minimize over fitting of the models by restricting the se-
lection of variables to those that had previously been
identified as relevant based on clinical experience and
from literature. Candidate variables for the model in-
cluded age, educational status, previous cervical cancer
screening, distance from residence to health facility and
type of residence. The odds ratios with 95% confidence
intervals were calculated for each variable.
Ethical considerations
Approval for the study was obtained from the Institutional
Review Board, Nigerian Institute of Medical Research,
Lagos Nigeria. A written informed consent was obtained
from the women invited to be part of the study after de-
tailed information about the study. Impartial witnesses
who were not members of the team assisted the consent-
ing process for the low literates.
Results
A total of 751 women attended the outreach programme
during the study period; of which 673(89.6%) consented
to be part of the study. A total of 108 (16.1%) were
found positive to direct visual inspection and constituted
the study population (Figure 1). Forty (6.4%) of the 629
women that accepted to be screened for HIV tested posi-
tive. Of the forty, only seven screened positive to DVI.
Sociodemographic and reproductive characteristics
The socio-demographic and reproductive characteristics
of the 108 women who screened positive to DVI are pre-
sented in Table 1. Seventy four (68.5%) participants re-
sided in a rural community compared to 34 (31.5%) that
lived in an urban community. The approximate distance
Women that attended 
the community out 
reach programme
n-751
Eligible for screening for 
inclusion into the study  
n=673
Served as comparator 
group                
(non-defaulters)        
n=57
Kept follow up  
appointment 
Did not keep follow up  
appointment 
(defaulters)         
n=51
Did not give consent 
to be part of the 
study n=78
Screened positive to 





Figure 1 Study participation and follow up status.
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around 70 km, with the majority residing within 20 km
of the clinic (63.9%). Only 12.0% of the women resided
more than 50 km from the clinic. The mean age of the
women was 39 ± 7 years (range 18–76). The majority of
the participants were between 30 to 49 (65.7%) years of
age. Married women (72.6%) and those of parity 1–4
(64.3%) were in the majority. Seventy eight (72.2%)
women had completed at least secondary level educa-
tion, 19 (17.6%) had completed primary education and
10 (9.3%) women had no formal education. The majority
of the 108 women engaged in income generating activ-
ities (98; 90.7%), did not use a modern contraceptive
method (76; 70.4%) and had not been subjected to
cervical cancer screening prior to present screening
(86; 79.6%).Pattern of and reasons for default
Fifty-one (47.2%) women out of the 108 that tested posi-
tive to DVI defaulted from the scheduled follow-up care
appointment. Of the 51 defaulters, fifteen (29.4%) were
completely lost as both their phone number and home
addresses were incorrect and therefore could not be lo-
cated. The reasons for default among the 36 women that
were reached were unaffordability of transportation and
treatment cost (48.6%), time constraint (25.7%), ‘I believe
nothing is wrong with me’ (11.4%), ‘the clinic is too far
from my house’ (8.6%) and ‘I am sick’ (5.7%).
Predictors of default from follow-up care
The results of the association between the outcome
variable “default from follow-up care” and the socio-
demographic and reproductive characteristics are shown
in Table 2. A greater proportion of women who defaulted
from follow-up care after screening positive to DVI had
less than secondary education (OR: 2.9,95% CI: 1.1 –7.7)
and lived in a rural community (OR: 2.78, CI:1.1 – 7.3)
Women who resides more than 10 km from the clinic
(OR: 3.6, CI:1.5 – 9.1), and had never screened for cervical
cancer (OR: 3.9, CI:1.2–13.4) were in the majority com-
pared to their counterparts who reside less than 10 km
from the clinic and had screened for cervical cancer previ-
ously. No significant association was found between age,
parity, marital status, work status, current contraceptive
use and default from follow-up care. After controlling for
confounders of educational status, work status, type of
community and current contraceptive use in a multivari-
ate logistic regression model, only 3 variables retained
their independent significant association with default from
follow up care appointment. These variables were having
less than secondary education (OR = 3.1, CI: 2.0-5.2), res-
iding more than 10 km from the clinic (OR: 2.0,95% CI:
1.0-4.1) and no previous cervical cancer screening experi-
ence (OR: 3.5, 95% CI: 3.1-8.4).
Discussion
While some studies have evaluated the DVI test outcome,
there is limited knowledge regarding default of follow-up
care and associated factors after screening positive to cer-
vical cancer [25-28]. This study was designed to fill this
knowledge gap and to use the information obtained as ad-
vocacy tool for the improvement of the current opportun-
istic and outreach based cervical cancer screening in our
sub-region. Overall 108 (16.0%) of 673 women tested posi-
tive to DVI; of which 47.2% defaulted from follow-up care
appointment. The default rate in this study is much higher
than rates reported from other low income countries and
may be due to differing sociocultural, environmental and
health system issues [5,18,23]. In Nigerian women are
social-culturally expected to be subservient to their spouse
and thus needs their permission to honour invitations
Table 1 Socio-demographic and reproductive
characteristics of the 108 women who screened positive
to direct visual inspection


























Type of community (108)
Urban 34(31.5)
Rural 74(68.5)







Current use of contraceptive (108)
Using 32(29.6)
Not using 76(70.4)
Previous cervical cancer test (108)
Screened 22(20.4)
Not screened 86(79.6)
Table 1 Socio-demographic and reproductive
characteristics of the 108 women who screened positive
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centage of women especially in rural areas are not gain-
fully employed depending on their spouse for their daily
sustenance. Even transportation fees are provided by their
spouse and thus need his concurrence to attend clinic for
follow up. Poor public transportation and health systems
are other challenges confronting the women and making
it difficult to honour such invitation [18,23]. A large per-
centage of Nigerian women prefer to present in private
health facilities because of the long waiting time and poor
quality of services in public facilities [36,37]. Cost of trans-
portation is also out of reach for poor peasants in the rural
communities [36]. In the final analysis the choice the
women make will depend on having to choose between
keeping an appointment for a “disease they are not aware
off” to “disobeying” their spouses with its possible conse-
quences including violence [32,38]. The women are also
mindful of the fact that in a country with poor health
system and its attendant long waiting time, keeping ap-
pointment do not equate to finding solution to their
“health challenge”. Furthermore the encroachment of the
churches and mosques in health care without providing
health infrastructure like the traditional mission hospitals
could be a contributor [35]. In our earlier study on the
willingness to screen for cervical cancer, the second most
common reason for refusal of the test was related to cli-
ent’s religious belief and teaching [23]. Some clients
were of the opinion that they cannot have cervical can-
cer because of their religious belief. It may therefore be
correct to assume that some participants in this study
with similar belief may have defaulted.
Cervical cancer prevention programme that adopts a
“see and treat” strategy could best suit the women in the
setting described above. Several studies in sub Saharan
African that evaluated the “see and treat” strategy reported
very good outcome with significant reduction in default
rate [26,39-42] The reduction in default rate was attrib-
uted to the reduction in number of visits, reduced service
and transportation costs as well reduction in man hours
of work [39-41].
Poorly educated women, living more than 10 km from
the clinic and had never screened for cervical cancer in
this study were more likely to default from follow-up care
appointment than their more educated counterparts, res-
iding less than 10 km from the clinic and had previously
screened for cervical cancer. The main reasons for default
Table 2 Association between default from follow-up care after screening positive to precancerous lesion of the cervix
and sociodemographic and reproductive characteristics of the participants (n = 108)
Characteristics Defaulter
(%) n = 51
Non defaulter
(%) n = 57
Crude result Adjusted result
Crude OR (95% CI) P value Adjusted OR (95% CI) P value
Age (years)
<40 25(49.0) 20(35.1) 1.8(0.8 – 4.2) 0.20 1.2(0.8 – 6.9) 0.23
≥40 26(51.0) 37(64.9) 1(ref) 1(ref)
Parity
≤2 15(29.4) 18(31.6) 2.0(0.8 – 5.6) 0.88 1.1(0.5 – 8.1) 0.95
>2 3(70.6) 35(68.4) 1(ref) 1(ref)
Education status
< Secondary 19(37.5) 10(17.5) 2.9(1.1 – 7.7) 0.03 3.1(2.0 – 5.2)a 0.02
≥ Secondary 31(62.7) 47(82.5) 1(ref) 1(ref)
Marital Status
Not married 14(27.5) 9(15.8) 2.0(0.7 – 5.6) 0.23 1.3(0.8 – 6.9) 0.26
Married 37(72.5) 47(84.2) 1(ref) 1(ref)
Work status
Not working 27(52.9) 19(33.3) 2.3(1.0 – 5.4) 0.06 1.2(0.8 – 8.1) 0.11
Working 23(47.1) 37(66.7) 1(ref) 1(ref)
Type of Community
Urban 10(19.6) 23(40.4) 1(ref) 0.03 1(ref) 0.07
Rural 41(80.4) 34(59.6) 2.8(1.1 – 7.3) 1.6(0.9 –9.1)
Distance of residence to clinic
< 10 Km 11(21.6) 25(43.9) 1(ref) 0.02 1(ref) 0.03
≥ 10 Km 40(78.4) 32(56.1) 2.8(1.1 – 7.3) 2.0(1.0 –4.1)b
Current contraceptive use
Using 10(19.6) 22(38.6) 1(ref) 0.05 1(ref) 0.08
Not using 41(80.4) 35(61.4) 2.6(1.0 -6.8) 1.4(0.3 – 9.7)
Previous cervical cancer screen
Screened 5(9.8) 17(29.8) 1(ref) 0.02 1(ref)
Never Screened 46(90.2) 40(70.2) 3.9(1.2 –13.4) 3.5(3.1 – 8.4)c 0.006
HIV status
Positive 3(5.9) 4(7.0) 0.8(0.1-4.7) 0.66 0.8(0.2-5.1) 0.81
Negative 48(94.1) 53(93.0) 1(ref) 1(ref)
Note: Potential confounders adjusted at multivariate logistic regression analysis. aAdjusted for work status, bAdjusted for type of community and work status,
cAdjusted for educational status and current contraceptive use.
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be reached (about half ) and the main reasons given
were unaffordability of transportation and treatment
cost (48.6%), time constraints (25.7%) and ‘I believe
nothing is wrong with me”.
The DVI positivity rate among the women in the
study is 16.1% and thus within the range of 2% to 16%
reported by studies conducted in Tanzania, Mali and
Botswana [39,43,44]. It is also lower than 32.6% and
43.7% reported from South Africa and Zambia, respect-
ively [45,46]. The lower rate in our study may be due to
the lower HIV prevalence in the study communitiescompared to South Africa and Zambia [29]. A number
of studies in sub Saharan Africa have reported a signifi-
cant association between HIV infection and invasive
cervical cancer [18,23,24,27,39,44,47]. In the presence of
HIV infection, there is the persistence of cervical cancer-
causing Human Papilloma Virus in the uterine cervix. The
persistence of high-risk HPV types in the transformation
zone of the cervix ultimately leads to malignant changes
in the cervix [1,9,18].
The proportion of women who tested positive to DVI
and did not attend the follow-up care appointment in
this study (47.2%) is higher compared with findings from
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[24]. The high default rate across the three studies most
likely underscores the general lack of awareness and
poor knowledge of cervical cancer and the importance
of early diagnosis and treatment of cervical cancer among
women in sub Saharan Africa [18,20,23]. Efforts are re-
quired to sensitize women to the serious consequences of
untreated cervical cancer and the advantages of an early
identification of premalignant lesions of the cervix. In
addition, interventions should, besides screening, also in-
clude follow-up care through the process until treated or
discharged from the clinics. Several countries in sub
Saharan African and Southeast Asia have adopted the “see
and treat strategy” in order to ensure prompt treatment
and consequently prevention of default, a strategy found
to be effective also in the hands of nurses and clinical offi-
cers [10,25,28]. Besides reducing cost and saving lives it
will also address the reasons for default from follow-up
care provided by the participants namely transportation
cost and time constraints. This will most likely encourage
more women to take the test, as it will eliminate repeat
visit and long waiting time in public institutions.
The study was also able to establish the predictors for
follow-up care default among women that screened posi-
tive to DVI. Those with poor educational status, residing
more than 10 km from the clinic and who had not
screened previously were more likely to default from
follow-up care visit. This finding is in keeping with
several studies in Nigeria and elsewhere, which show
that poorly educated women and those who have never
accessed reproductive health services are very likely to
default from accessing other reproductive health ser-
vices [18,20,23,24,27]. Poorly educated women may not
be aware of the importance of positive cervical cancer
screening and the follow-up visits. In addition, they are
likely not to be gainfully employed, thus depending on
spouses to finance all their needs including reproductive
health services. The fact that apart from screening, all
other services relating to confirmation and treatment of
cervical cancer are not free may have demotivated the
women from keeping the appointment. After all it may
appear pointless spending limited resources to keep the
appointment to women who may not afford the defini-
tive treatment if confirmed positive.
The distance from the community to the clinic and
the time spent travelling and waiting for services is an-
other barrier found to keep women from follow-up ap-
pointment [18,23,24,28]. This is similarly confirmed by
this study which showed that women who resided more
than 10 km from the clinic were twice likely to default
than those who reside within 10 km of the clinic.
Findings from this study confirmed our suspicion that
significant numbers of women do not keep their follow-up
appointment after screening positive to precancerouslesion. The reasons of cost of transportation and lack of
time to keep the appointment are in keeping with findings
in previous studies conducted in Ivory coast, Thailand,
Mexico and Zambia for non-uptake of reproductive health
services [4,5,15,16,24]. The findings confirm the long
known fact that service provision alone is not sufficient
for services uptake [5]. Rather issues of geographic access,
low status of women, inadequate or lack of education and
poverty are the major determinants of service uptake
[6,14,15]. The factors found to be associated with default
and reasons for defaults in this study confirm this. Female
education and empowerment, community involvement
and provision of cervical cancer services in the commu-
nity are therefore the likely keys to the reduction of de-
fault form cervical cancer services [20,23,44].
Limitations of the study
The number of events in this study was small and there
was the likelihood of over fitting the model during ana-
lysis. We minimized this by restricting the selection of
variables to only those that had been identified as rele-
vant based on clinical experience and previous literature.
Conclusion
The findings from this study contributed to the growing
body of evidence indicating that the current strategy of
opportunistic testing and outreach cervical cancer screen-
ing programme is associated with high rates of default.
The multiple visits associated with this strategy and cost
implication makes it burdensome and unattractive to
poorly educated women residing several kilometres
from the few hospitals and clinics offering unaffordable
services. The modification of the present cervical cancer
prevention and treatment programme is recommended.
This should include:
1. Public health education should lay emphasis on the
natural history of precancerous lesion and the
importance of breaking the process.
2. Assuring women who test positive that cervical
cancer is preventable and treatable if identified early.
3. Changing of the present multi-visit strategy to a
single visit strategy of “see and treat” to ensure that
all the women who test positive receive the
lifesaving treatment.
4. Motivation of women to take up cervical cancer
prevention and treatment services by making
all cervical cancer services affordable if not
completely free.
5. Decentralization of cervical cancer services to the
rural areas using midwives and medical officers.
6. Integration of cervical cancer screening into existing
reproductive health services like HIV and family
planning programme.
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